The innovative drug sector opened up sharply. Hanson Pharmaceuticals, Harbin Sanlian 2, Haixin, Zhongguancun, Laimei Pharmaceutical, Watson Biotech, Shuanglu Pharmaceutical, Kangchen Pharmaceutical, and Yuekang Pharmaceutical rose to a standstill, Ternary Gene rose more than 20%, Zhifei Biotech and Petrochemical Innovation rose more than 15%, and Xinyuan, Anke Biotech, and Kangtai Biotech rose more than 10%.

Zhitongcaijing · 3d ago
The innovative drug sector opened up sharply. Hanson Pharmaceuticals, Harbin Sanlian 2, Haixin, Zhongguancun, Laimei Pharmaceutical, Watson Biotech, Shuanglu Pharmaceutical, Kangchen Pharmaceutical, and Yuekang Pharmaceutical rose to a standstill, Ternary Gene rose more than 20%, Zhifei Biotech and Petrochemical Innovation rose more than 15%, and Xinyuan, Anke Biotech, and Kangtai Biotech rose more than 10%.